Breaking News Instant updates and real-time market news.

AAPL

Apple

$177.75

0.65 (0.37%)

, AMZN

Amazon.com

$1,523.71

28.11 (1.88%)

15:29
11/21/18
11/21
15:29
11/21/18
15:29

Apple weighed new connected TV 'dongle,' Information reports

Apple (AAPL) has held internal discussions about releasing a low-priced streaming "dongle" that users could plug into the back of their television sets, similar to Amazon's (AMZN) Fire Stick or Google's (GOOG) Chromecast, the Information reports, citing people familiar with the project. The device could make Apple's upcoming video streaming service more widely available, the report notes. Reference Link

AAPL

Apple

$177.75

0.65 (0.37%)

AMZN

Amazon.com

$1,523.71

28.11 (1.88%)

GOOG

Alphabet

$1,044.26

18.26 (1.78%)

GOOGL

Alphabet Class A

$1,050.29

19.07 (1.85%)

  • 28

    Nov

  • 04

    Dec

  • 04

    Dec

  • 03

    Mar

AAPL Apple
$177.75

0.65 (0.37%)

11/15/18
MSCO
11/15/18
NO CHANGE
Target $253
MSCO
Overweight
Apple dip a buying opportunity amid supply chain 'noise,' says Morgan Stanley
Morgan Stanley analyst Katy Huberty called the 8.5% decline in Apple (AAPL) shares following Lumentum's (LITE) and Qorvo's (QRVO) negative pre-announcements this week a buying opportunity, noting that she is still bullish on the iPhone maker's Services growth. Services will "take the growth baton" from Devices as the smartphone market matures, contends Huberty. While she believes investors should focus on Services rather than iPhone units, Huberty also believes Apple's December quarter guidance incorporates the revisions made by Lumentum and Qorvo, adding that unit revisions are typically more severe for the supply chain than Apple given inventory fluctuations and the company's steps to ensure adequate supply early in a product launch. Huberty keeps an Overweight rating and $253 price target on Apple shares.
11/15/18
11/15/18
UPGRADE
Target $55

Equal Weight
Qualcomm upgraded to Equal Weight after expectations reset at Morgan Stanley
As previously reported, Morgan Stanley analyst James Faucette upgraded Qualcomm (QCOM) to Equal Weight from Underweight as he thinks consensus estimates now imply a more realistic scenario for QCT margins and that lowered expectations on a resolution with Apple (AAPL) gives room for the stock to react positively should legal proceedings trigger a settlement. He believes the stock's underperformance suggests the market has "appropriately" lowered expectations, Faucette added. He maintains a $55 price target on Qualcomm shares.
11/16/18
MSCO
11/16/18
DOWNGRADE
MSCO
Equal Weight
TSMC downgraded to Equal Weight from Overweight at Morgan Stanley
Morgan Stanley analyst Charlie Chan downgraded TSMC (TSM) to Equal Weight from Overweight, stating that he is concerned that recent Apple (AAPL) iPhone supply chain order cuts "could be just the first wave" and weak orders from Apple "could be a new normal for TSMC" if next year's iPhone doesn't have attractive features. Chan, who doesn't think secular growth drivers are strong enough to differentiate the stock in a logic semi downcycle, lowered his price target on TSMC shares to NT$239 from NT$253.
11/20/18
GSCO
11/20/18
NO CHANGE
Target $182
GSCO
Neutral
Apple price target lowered to $182 from $209 at Goldman Sachs
Following The Wall Street Journal's report yesterday about Apple seeing lower demand than the company had initially expected for its new iPhones, Goldman Sachs analyst Rod Hall noted that it appears that in addition to weakness in China and other emerging markets it also looks like the price and features of the iPhone XR may not have been well-received by non-U.S. users. While he believes the company likely included this more negative scenario in its guidance, Hall sees "material risk" to Apple's March quarter guidance if current demand trends continue, he tells investors. He lowered his price target on the shares to $182 from $209 to reflect a multiple more toward the middle of the stock's three year range and keeps a Neutral rating on Apple.
AMZN Amazon.com
$1,523.71

28.11 (1.88%)

11/21/18
OPCO
11/21/18
NO CHANGE
OPCO
AWS has long runway for future growth, says Oppenheimer
Oppenheimer analyst Timothy Horan says that Amazon Web Services (AMZN), AWS, continues to move up the stack improving Security, AI/ML, IoT, Database services and bundling in with infrastructure to maintain prices of legacy services. The analyst expects a number of new features and tools for Lambda, Aurora and Greengrass. He also sees Amazon discussing UC&C, gaming and blockchain. AWS kicked off its hybrid offering with its VMware (VMW) partnership and Kubernetes support, but it still lacks the full stack that Microsoft (MSFT) has for hybrid deployments-which are critical for enterprise customers that want to capture the benefits of the cloud while still maintaining on-premise datacenters for sensitive workloads, he contends. Overall, Horan believes demand remains strong, and thinks only about 25% of total enterprise workloads have moved to the cloud, which gives AWS a long runway for future growth.
11/21/18
11/21/18
UPGRADE
Target $65

Neutral
Best Buy upgraded to Neutral following quarterly results at Wedbush
As previously reported, Wedbush analyst Michael Pachter upgraded Best Buy (BBY) to Neutral from Underperform, with a $65 price target, saying it has consistently defied his expectations and the company appears to have settled on the right formula for long-term growth. The analyst applauds Best Buy for its many accomplishments, not least of which is achieving the difficult financial targets it has set for itself year after year. While Pachter stills harbor some concerns, including competition from Amazon (AMZN), he thinks Best Buy is poised to deliver on its promises in the coming years.
11/21/18
ARGS
11/21/18
NO CHANGE
Target $205
ARGS
Buy
AvalonBay price target raised to $205 from $196 at Argus
Argus analyst Jacob Kilstein raised his price target on AvalonBay (AVB) to $205 and kept his Buy rating, citing the company's better than expected Q3 earnings along with his diminishing concerns about housing oversupply in New York over the near term. The analyst specifically expects the company to benefit from Amazon.com (AMZN) selection of New York's Long Island City as a location of its new headquarters. Kilstein believes that the 5% decline in AvalonBay stock price since June of 2017 offers a favorable entry and contends that the headwinds of higher interest rates and oversupply in some area have been priced in.
11/21/18
LEER
11/21/18
NO CHANGE
LEER
Humana-Walgreens strategic deal makes sense, takeout less likely, says Leerink
Following a media report saying that Humana (HUM) and Walgreens Boots Alliance (WBA) are in talks to take stakes in each other and possibly expand their retail clinic partnership inked on June 19, Leerink analyst Ana Gupte says she believes it makes strategic sense, though she believes an outright takeout is less likely given the multiple differential. As MCOs backward integrate into care delivery, the analyst believes a closer strategic alignment between the two companies can help Humana better compete with the likes of CVS (CVS)-Aetna (AET) and Optum-UnitedHealth (UNH) in the Medicare Advantage market while allowing Walgreens to further stave off e-commerce threats such as Amazon (AMZN), though Humana maintains its strategic investment focus on the home healthcare setting for Seniors.
GOOG Alphabet
$1,044.26

18.26 (1.78%)

11/15/18
MSCO
11/15/18
NO CHANGE
MSCO
Morgan Stanley highlights four tech stocks to buy following recent pullback
Morgan Stanley analysts Katy Huberty, Keith Weiss, Brian Nowak, Joe Moore, James Faucette and Brian Essex collaborated on a report addressing technology stocks following the recent market pullback, contending the fact that technology sector concentration remains near all-time highs suggests that its "probably too early" to buy the sector broadly. However, they highlight four stocks - Alphabet (GOOGL), Take-Two Interactive (TTWO), Microsoft (MSFT) and Xilinx (XLNX) - for which they believe the pullback is not fundamentally driven and the companies have strong secular tailwinds. The firm's analyst call these four stocks their "highest conviction" names and maintain Overweight ratings on all four.
11/19/18
JMPS
11/19/18
NO CHANGE
Target $1375
JMPS
Outperform
JMP says former Oracle exec well positioned to keep scaling Google Cloud
Following Google's announcement last week that Google Cloud CEO Diane Greene is stepping down in January and being replaced in that role by Thomas Kurian, who most recently served as President of Product Development at Oracle (ORCL), JMP Securities analyst Ronald Josey said he was somewhat surprised but believes Kurian is well positioned to continue scaling Google Cloud and growing its sales force. Josey maintains an Outperform rating and $1,375 price target on shares of Google parent Alphabet (GOOGL).
11/21/18
PIPR
11/21/18
NO CHANGE
Target $157
PIPR
Overweight
Amended Verily agreement 'major win' for DexCom holders, says Piper Jaffray
After talking with management, Piper Jaffray analyst JP McKim believes the amended collaboration and license agreement with Alphabet's (GOOG, GOOGL) Verily "seems like a no brainer" and is a "major win for the long term value" of DexCom (DXCM) shareholders. The royalty payments from the original agreement have been eliminated and those would have been at least a 500 basis point headwind on the margin profile of DexCom's business, McKim tells investors in a research note. He expects the company to release some longer term margin targets at its analyst day and says "removing this future headwind is a major win." Further, DexCom is now the preferred continuous glucose monitoring supplier into Onduo's Type 2 diabetes management program, says the analyst. He reiterates an Overweight rating on the shares with a $157 price target.
11/21/18
SPHN
11/21/18
NO CHANGE
Target $170
SPHN
Overweight
Verily collaboration more favorable to DexCom after revision, says Stephens
Stephens analyst Chris Cooley said DexCom's (DXCM) revised agreement with Alphabet's (GOOGL) Verily makes DexCom the preferred CGM partner while also replacing the former royalty agreement with an enhanced equity stake. The revised pact "solidifies the long-term potential of the collaboration while setting-up a more favorable EBITDA profile" for DexCom, contends Cooley, who keeps an Overweight rating and $170 price target on DexCom shares.
GOOGL Alphabet Class A
$1,050.29

19.07 (1.85%)

TODAY'S FREE FLY STORIES

FB

Facebook

$143.24

2.93 (2.09%)

11:47
12/18/18
12/18
11:47
12/18/18
11:47
Hot Stocks
Facebook COO Sandberg says needs to step up efforts to curb misinformation »

Facebook COO Sheryl…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMT

American Tower

$162.39

1.47 (0.91%)

11:45
12/18/18
12/18
11:45
12/18/18
11:45
Conference/Events
American Tower management to meet with SunTrust »

Group luncheon to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

CPRX

Catalyst Pharmaceuticals

$2.43

0.085 (3.62%)

, ENDP

Endo

$9.45

(0.00%)

11:43
12/18/18
12/18
11:43
12/18/18
11:43
Hot Stocks
Catalyst Pharmaceuticals, Endo sign definitive agreement for vigabatrin tablets »

Catalyst Pharmaceuticals…

CPRX

Catalyst Pharmaceuticals

$2.43

0.085 (3.62%)

ENDP

Endo

$9.45

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TEVA

Teva

$17.39

-0.26 (-1.47%)

11:40
12/18/18
12/18
11:40
12/18/18
11:40
Options
Put buyer in Teva Pharmaceuticals appears to adjust week-old position »

Put buyer in Teva…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:40
12/18/18
12/18
11:40
12/18/18
11:40
General news
Oil Action: NYMEX crude »

Oil Action: NYMEX crude…

AMTB

Mercantil Bank

$12.30

(0.00%)

11:39
12/18/18
12/18
11:39
12/18/18
11:39
Hot Stocks
Breaking Hot Stocks news story on Mercantil Bank »

Mercantil Bank Holding…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Dec

AXGN

AxoGen

$26.39

-1.14 (-4.14%)

11:38
12/18/18
12/18
11:38
12/18/18
11:38
Periodicals
AxoGen mentioned cautiously in a Seeking Alpha article 

Reference Link

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMTB

Mercantil Bank

$12.30

(0.00%)

11:34
12/18/18
12/18
11:34
12/18/18
11:34
Hot Stocks
Breaking Hot Stocks news story on Mercantil Bank »

Mercantil Bank Holding…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Dec

MXIM

Maxim Integrated

$52.71

0.51 (0.98%)

, INTC

Intel

$48.02

0.93 (1.97%)

11:30
12/18/18
12/18
11:30
12/18/18
11:30
Recommendations
Maxim Integrated, Intel, Inphi, Cisco, Macom analyst commentary  »

Cisco acquisition of…

MXIM

Maxim Integrated

$52.71

0.51 (0.98%)

INTC

Intel

$48.02

0.93 (1.97%)

IPHI

Inphi

$33.50

0.96 (2.95%)

CSCO

Cisco

$44.04

-0.17 (-0.38%)

MTSI

Macom

$15.86

0.46 (2.99%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Jan

  • 07

    Jan

  • 08

    Jan

  • 10

    Jan

  • 04

    Mar

CBIO

Catalyst Biosciences

$8.93

-0.33 (-3.56%)

11:25
12/18/18
12/18
11:25
12/18/18
11:25
Conference/Events
Catalyst Biosciences to host research and development day »

Research and Development…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

WCG

WellCare

$231.35

-5.81 (-2.45%)

11:25
12/18/18
12/18
11:25
12/18/18
11:25
Conference/Events
WellCare management to meet with Wolfe Research »

Healthcare Services…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

PM

Philip Morris

$78.59

-2.8 (-3.44%)

, BTI

British American Tobacco

$32.48

-0.25 (-0.76%)

11:23
12/18/18
12/18
11:23
12/18/18
11:23
On The Fly
Fly Intel: Today's top analyst calls on Wall Street »

Check out today's top…

PM

Philip Morris

$78.59

-2.8 (-3.44%)

BTI

British American Tobacco

$32.48

-0.25 (-0.76%)

IMBBY

Imperial Brands

$0.00

(0.00%)

TSLA

Tesla

$346.73

-1.57 (-0.45%)

ORCL

Oracle

$45.66

-0.06 (-0.13%)

OSTK

Overstock.com

$13.06

-0.45 (-3.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Jan

  • 16

    Jan

  • 17

    Jan

USO

United States Oil Fund

$10.10

-0.345 (-3.30%)

11:20
12/18/18
12/18
11:20
12/18/18
11:20
Options
New 52wk lows prompt bullish risk reversal in US Oil ETF »

New 52wk lows prompt…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CPS

Cooper-Standard

$64.54

1.26 (1.99%)

11:18
12/18/18
12/18
11:18
12/18/18
11:18
Hot Stocks
Cooper-Standard announces plans for new world headquarters »

Cooper Standard announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GT

Goodyear Tire

$20.87

0.31 (1.51%)

11:17
12/18/18
12/18
11:17
12/18/18
11:17
Hot Stocks
Goodyear Tire to expand capacity of Slovenian manufacturing facility »

Goodyear announced plans…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

11:17
12/18/18
12/18
11:17
12/18/18
11:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

11:16
12/18/18
12/18
11:16
12/18/18
11:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LILAK

Liberty Global LiLAC

$16.32

0.01 (0.06%)

11:13
12/18/18
12/18
11:13
12/18/18
11:13
Conference/Events
Liberty Global LiLAC management to meet with Evercore ISI »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

  • 20

    Dec

EWZ

MSCI Brazil Index

$37.67

0.3644 (0.98%)

11:10
12/18/18
12/18
11:10
12/18/18
11:10
Options
Four-way option spread in Brazil Fund as shares climb 1.1% »

Four-way option spread in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:10
12/18/18
12/18
11:10
12/18/18
11:10
General news
Treasury announced $70 B in shorter dated bill auctions for Thursday »

Treasury announced $70 B…

11:10
12/18/18
12/18
11:10
12/18/18
11:10
General news
Atlanta Fed's Q4 GDPNow estimate was trimmed to 2.9% »

Atlanta Fed's Q4…

RBS

RBS

$5.36

0.15 (2.88%)

11:09
12/18/18
12/18
11:09
12/18/18
11:09
Hot Stocks
RBS appoints Katie Murray as CFO »

RBS announces the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:08
12/18/18
12/18
11:08
12/18/18
11:08
General news
8-Week Bill Announcement Offering Amount data reported »

8-Week Bill Announcement…

11:08
12/18/18
12/18
11:08
12/18/18
11:08
General news
4-Week Bill Announcement Offering Amount data reported »

4-Week Bill Announcement…

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$256.94

1.82 (0.71%)

11:08
12/18/18
12/18
11:08
12/18/18
11:08
Periodicals
White House wants to avoid government shutdown, Washington Post reports »

White House spokeswoman…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$256.94

1.82 (0.71%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.